Company / Capital Returned to Shareholders
Bio-Techne Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$326.1M
FY2025
5-year range
$63.8M / $326.1M
FY2021-FY2025
Trend
+150.0%
vs FY2024
Sector context
#42 of 108
Health Care
What the data says
At $326M, Bio-Techne's capital returned to shareholders ranks #42 of 108 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $47M in FY2017 to $326M in FY2025.
Based on SEC 10-K filings.
$326M in FY2025 with a 5-year CAGR of +26.9%.
Improved from $93M to $326M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +48.8%
- 5-Year CAGR
- +26.9%
- 10-Year CAGR
- -
Sector benchmark
-56.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.9%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 150.0% year-over-year.
- Ranks #42 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $326.1M | +150.0% |
| FY2024 | $130.5M | +40.6% |
| FY2023 | $92.8M | -6.3% |
| FY2022 | $99.0M | +55.3% |
| FY2021 | $63.8M | -35.6% |
| FY2020 | $99.0M | +55.3% |
| FY2019 | $63.8M | +32.9% |
| FY2018 | $48.0M | +1.4% |
| FY2017 | $47.3M | -0.6% |
| FY2016 | $47.6M | +1.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026